Rachel Beyer
Head - cGMP Viral Vector Laboratory National Cancer Institute
Seminars
Thursday 26th February 2026
The Clock is Ticking: Meeting Regulatory Burdens in a Patient-Centred Timeframe
11:30 am
- Reviewing how to design GMP-compliant viral vectors tailored for a single patient’s treatment needs
- Discussing strategies for releasing viral vectors in <3 weeks for single-patient treatments
- Anticipate scaling up processes from n=1 vectors to 20-40 patient batches
Wednesday 25th February 2026
Roundtable Discussion: Is Bigger Always Better? Defining the Right Scale to Effectively Balance Yield, Safety & Cost
11:30 am
- Contrasting scalability limitations across vector types and how physical constraints shape commercial strategy
- Discussing trade-offs between driving higher titres versus maintaining potency and how these challenges can differ across vector classes
- Deciding between ‘scaling up’ and ‘scaling out’ and how this can be affected by modality, indication, and regulatory expectation
